Sunday, December 05, 2021 5:11:27 PM
Publicly, in interviews, Guy has mentioned he would not spend investor monies on corporate trials if he did not feel positive about reaching the primary endpoint.
We also know that the current trial is open label, allowing results to be seen. One of the stated uses of the 18MM raise is for clinical trials.
I personally am ecstatic about this move and what it could mean for the future for patients and caregivers (and investors) and am even happier to accumulate more shares at a discount.
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM